Burning Rock Biotech (LSE:BNR) EV-to-EBITDA : 0.28 (As of Sep. 27, 2024)

Burning Rock Biotech EV-to-EBITDA Chart

Burning Rock Biotech Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
EV-to-EBITDA	Get a 7-Day Free Trial															-1.11	-0.15	-0.15	0.03	-0.10

Competitive Comparison of Burning Rock Biotech's EV-to-EBITDA

For the Diagnostics & Research subindustry, Burning Rock Biotech's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Burning Rock Biotech's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Burning Rock Biotech's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Burning Rock Biotech's EV-to-EBITDA falls into.

Burning Rock Biotech EV-to-EBITDA Calculation

Burning Rock Biotech's EV-to-EBITDA for today is calculated as:

Burning Rock Biotech's current Enterprise Value is $-21.98 Mil.
Burning Rock Biotech's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-78.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Burning Rock Biotech  (LSE:BNR) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Burning Rock Biotech's PE Ratio (TTM) for today is calculated as:

Burning Rock Biotech's share price for today is $3.562.
Burning Rock Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.655.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Burning Rock Biotech EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Burning Rock Biotech Business Description